Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A. Ference, Alberico L. Catapano, Ulrich Laufs et al.|European Heart Journal|2017Cited by 3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyBørge G. Nordestgaard, M. John Chapman, Steve E. Humphries et al.|European Heart Journal|2013Cited by 2.7k
Lipoprotein(a) as a cardiovascular risk factor: current statusBørge G. Nordestgaard, Anne Tybjærg‐Hansen, M. John Chapman et al.|European Heart Journal|2010Cited by 1.8k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus PanelJan Borén, Henry N. Ginsberg, M. John Chapman et al.|European Heart Journal|2020Cited by 1.5k
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM. John Chapman, Henry N. Ginsberg, Pierre Amarenco et al.|European Heart Journal|2011Cited by 1.2k